Skip to main content
. 2021 Jan 14;6(3):2074–2084. doi: 10.1021/acsomega.0c05054

Figure 6.

Figure 6

Antioxidant potential of rosuvastatin evaluated by (A) DPPH free radical scavenging assay and (B) ferric reducing assay. Data are represented as mean ± SEM (n = 6) and analyzed by two-way ANOVA followed by the Bonferroni post-test, and p < 0.05 is considered significant compared to disease control, where ***p < 0.001, **p < 0.01, *p < 0.05, ns = not significant.